IL11 and Thrombocytopenia: Recombinant IL-11 is an FDA-approved drug (oprelvekin; Neumega®) used against chemotherapy-induced thrombocytopenia (http://www.fda.gov/cder/biologics/products/opregen112597.htm) [14].